T Cell–Derived IL-22 Amplifies IL-1β–Driven Inflammation in Human Adipose Tissue: Relevance to Obesity and Type 2 Diabetes

Proinflammatory cytokines are critically involved in the alteration of adipose tissue biology leading to deterioration of glucose homeostasis in obesity. Here we show a pronounced proinflammatory signature of adipose tissue macrophages in type 2 diabetic obese patients, mainly driven by increased NLRP3-dependent interleukin (IL)-1β production. IL-1β release increased with glycemic deterioration and decreased after gastric bypass surgery. A specific enrichment of IL-17- and IL-22-producing CD4+ T cells was found in adipose tissue of type 2 diabetic obese patients. Coculture experiments identified the effect of macrophage-derived IL-1β to promote IL-22 and IL-17 production by human adipose tissue CD4+ T cells. Reciprocally, adipose tissue macrophages express IL-17 and IL-22 receptors, making them sensitive to IL-17 and IL-22. IL-22 increased IL-1β release by inducing pro-IL-1β transcription through activation of C-Jun pathways in macrophages. In sum, these human data identified IL-1β and the T-cell cytokine IL-22 as key players of a paracrine inflammatory pathway previously unidentified in adipose tissue, with a pathological relevance to obesity-induced type 2 diabetes. These results provide an additional rationale for targeting IL-1β in obesity-linked type 2 diabetes and may have important implications for the conception of novel combined anti-IL-1β and anti-IL-22 immunotherapy in human obesity.

[1]  V. Hombach,et al.  T-lymphocyte Infiltration in Visceral Adipose Tissue: A Primary Event in Adipose Tissue Inflammation and the Development of Obesity-Mediated Insulin Resistance , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[2]  Jean-Daniel Zucker,et al.  Cathepsin S, a novel biomarker of adiposity: relevance to atherogenesis , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  L. Joosten,et al.  The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. , 2010, Cell metabolism.

[4]  S. Malozowski,et al.  Interleukin-1-receptor antagonist in type 2 diabetes mellitus. , 2007, The New England journal of medicine.

[5]  Jean-Daniel Zucker,et al.  FunNet: an integrative tool for exploring transcriptional interactions , 2008, Bioinform..

[6]  L. Weiss,et al.  CD14+CD16++ cells derived in vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell‐like characteristics , 2000, European journal of immunology.

[7]  E. Schmitt,et al.  IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+ T lymphocytes. , 1998, Journal of immunology.

[8]  André Tchernof,et al.  Pathophysiology of human visceral obesity: an update. , 2013, Physiological reviews.

[9]  Yoichiro Iwakura,et al.  Review Functional Specialization of Interleukin-17 Family Members , 2022 .

[10]  S. Gaffen,et al.  IL-17 in obesity and adipogenesis. , 2010, Cytokine & growth factor reviews.

[11]  M. Giera,et al.  Adipocyte‐derived lipids modulate CD4+ T‐cell function , 2013, European journal of immunology.

[12]  R. Flavell,et al.  Recent advances in IL-22 biology. , 2011, International immunology.

[13]  S. Kaveri,et al.  Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. , 2012, The American journal of pathology.

[14]  K. Clément,et al.  SMRT-GPS2 corepressor pathway dysregulation coincides with obesity-linked adipocyte inflammation. , 2013, The Journal of clinical investigation.

[15]  J. Gugenheim,et al.  Identification of Adipose Tissue Dendritic Cells Correlated With Obesity-Associated Insulin-Resistance and Inducing Th17 Responses in Mice and Patients , 2012, Diabetes.

[16]  D. Patel,et al.  Effect of IL-17A blockade with secukinumab in autoimmune diseases , 2012, Annals of the rheumatic diseases.

[17]  M. Tschöp,et al.  Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. , 2007, The Journal of clinical investigation.

[18]  C. Benoist,et al.  Tissular T(regs): a unique population of adipose-tissue-resident Foxp3+CD4+ T cells that impacts organismal metabolism. , 2011, Seminars in immunology.

[19]  R. Kitazawa,et al.  MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. , 2006, The Journal of clinical investigation.

[20]  H. Roche,et al.  Lack of Interleukin-1 Receptor I (IL-1RI) Protects Mice From High-Fat Diet–Induced Adipose Tissue Inflammation Coincident With Improved Glucose Homeostasis , 2011, Diabetes.

[21]  F. Pociot,et al.  Interferon-gamma induces interleukin-1 converting enzyme expression in pancreatic islets by an interferon regulatory factor-1-dependent mechanism. , 2000, The Journal of clinical endocrinology and metabolism.

[22]  D. Artis,et al.  Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A , 2010, The Journal of experimental medicine.

[23]  P. Ghezzi,et al.  IL-1 induces IL-1. IV. IFN-gamma suppresses IL-1 but not lipopolysaccharide-induced transcription of IL-1. , 1990, Journal of immunology.

[24]  R. Sabat,et al.  Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. , 2010, Cytokine & growth factor reviews.

[25]  K. Cho,et al.  Adipose Tissue Macrophages Function As Antigen-Presenting Cells and Regulate Adipose Tissue CD4+ T Cells in Mice , 2013, Diabetes.

[26]  M. Neurath,et al.  Cutting Edge: IL-12 and IL-18 Differentially Regulate the Transcriptional Activity of the Human IFN-γ Promoter in Primary CD4+ T Lymphocytes , 1998, The Journal of Immunology.

[27]  M. Fasshauer,et al.  Insulin-sensitive obesity. , 2010, American journal of physiology. Endocrinology and metabolism.

[28]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[29]  M. Colonna,et al.  Accepted Manuscript Association Between Specific Adipose Tissue CD 4 + T-Cell Populations and Insulin Resistance in Obese People , 2013 .

[30]  Andrea De Gaetano,et al.  Double-Blind, Randomized Study Evaluating the Glycemic and Anti-inflammatory Effects of Subcutaneous LY2189102, a Neutralizing IL-1β Antibody, in Patients With Type 2 Diabetes , 2013, Diabetes Care.

[31]  E. Butcher,et al.  IL-17 Regulates Adipogenesis, Glucose Homeostasis, and Obesity , 2010, The Journal of Immunology.

[32]  K. Clément,et al.  Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: influence of glycemic status. , 2009, Journal of hepatology.

[33]  K. Clément,et al.  Expression of NLRP3 inflammasome and T cell population markers in adipose tissue are associated with insulin resistance and impaired glucose metabolism in humans. , 2012, Molecular immunology.

[34]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[35]  S. Woo,et al.  IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1β by keratinocytes via the ROS-NLRP3-caspase-1 pathway. , 2012, International immunology.

[36]  K. Maedler,et al.  XOMA 052, an anti-IL-1{beta} monoclonal antibody, improves glucose control and {beta}-cell function in the diet-induced obesity mouse model. , 2010, Endocrinology.

[37]  L. Fouser,et al.  Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides , 2006, The Journal of experimental medicine.

[38]  Z. Ling,et al.  High Fat Diet Induces Formation of Spontaneous Liposarcoma in Mouse Adipose Tissue with Overexpression of Interleukin 22 , 2011, PloS one.

[39]  J. Capeau,et al.  Long-term treatment with interleukin-1β induces insulin resistance in murine and human adipocytes , 2006, Diabetologia.

[40]  M. Donath,et al.  Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes , 2012, Diabetes Care.

[41]  N. Rose,et al.  Macrophages participate in IL‐17‐mediated inflammation , 2012, European journal of immunology.

[42]  L. Joosten,et al.  Inflammasome is a central player in the induction of obesity and insulin resistance , 2011, Proceedings of the National Academy of Sciences.

[43]  K. Clément,et al.  Variations in circulating inflammatory factors are related to changes in calorie and carbohydrate intakes early in the course of surgery-induced weight reduction. , 2011, The American journal of clinical nutrition.

[44]  M. Donath,et al.  Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity. , 2013, Cell metabolism.

[45]  S. Brownell,et al.  Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity. , 2008, Cytokine.

[46]  C. Apovian,et al.  Adipose Macrophage Infiltration Is Associated With Insulin Resistance and Vascular Endothelial Dysfunction in Obese Subjects , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[47]  M. Lafontan,et al.  Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity. , 2009, Biochemical and biophysical research communications.